🔴 Telix Pharmaceuticals is trading 4.1% down today on capital structure disclosures and high short interest

Telix Pharmaceuticals is trading 4.1% down at $11.23 following multiple ASX filings regarding changes to its securities.

• Investors are reacting to a series of notifications including the cessation of securities, unquoted securities, and an application for quotation.
• Elevated short interest, currently exceeding 12%, may be amplifying the price decline as traders reposition in response to these capital-structure disclosures.
• The stock's sharp move lower stands out against a broadly flat performance in the wider market.